EV and pembrolizumab doubling PFS and OS in 1st line UC compared to chemotherapy @NEJM
Uromigos
@Uromigos
The Uromigos strives to provide balanced, scientific content related to care of patients with GU malignancies. Click the link below to listen to our podcasts.
